alexa
Reach Us +44-1625-708989
Rekindling The Hope: Obese Patients Seeking A Kidney Transplant | 9182
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rekindling the hope: Obese patients seeking a kidney transplant

2nd International Conference on Nephrology & Therapeutics

Pradeep V. Kadambi

Accepted Abstracts: J Nephrol Therapeutic

DOI: 10.4172/2161-0959.S1.011

Abstract
C urrently in the United States, 35.7% of adults are obese (BMI ≥ 30) and this demographic also represents the patients who have end stage kidney disease. Obese patients on dialysis wait longer to receive a kidney transplant compared to their non-obese counterparts. There are many reasons behind this but perhaps several factors such as risk of delayed graft function, wound complications, inferior allograft survival and other co morbidities make these patients not the greatest candidates for kidney transplantation. Additionally, obese patients do very well on dialysis (obesity-dialysis paradox). Our paper examines the barriers for obese patients to receive a kidney transplant and how we could help those patients overcome the barriers and get them transplanted.
Biography
Pradeep V. Kadambi completed his MBBS training at Bangalore Medical College and then was trained at the Hospital of Saint Raphael, a Yale affiliate, in Internal Medicine and Nephrology, and pursued a Transplant Nephrology fellowship at the University of Chicago. He was faculty at the University of Chicago till UTMB recruited him. He held leadership positions including the Director of the Nephrology Outpatient Practice, and the Director of the Medicine Inpatient Bed Flow Control. He also successfully completed an MBA from the Kellogg School of Management with majors in Leadership in Organizations and Marketing. He currently serves as the Medical Director of Kidney and Pancreas Transplantation and the Chair of the Physician Engagement and Marketing Committee
Relevant Topics
Top